Antiliver Fibrosis Screening of Active Ingredients from Apium graveolens L. Seeds via GC-TOF-MS and UHPLC-MS/MS

Table 2

Effects of TGF-β1 on liver fibrosis indexes (mean ± SD, n = 3).

Group	Dose (ng·mL^−1)	LN (μg·L^−1)	HA (ng·L^−1)	PCIII (μg·L^−1)
Blank control	—	51.8 ± 0.78	26.9 ± 5.67	18.8 ± 4.53
Model group (TGF-β1)	100	833.4 ± 9.94^##	302.3 ± 7.44^##	115.3 ± 3.38^##

Compared with the blank control group (, ).